BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

LD-2 disclosure · 1st Quarter - Report

FIGHT COLORECTAL CANCER

via MS. MARGARET CARVIN

1st Quarter (Jan 1 - Mar 31) · 2017Posted Mar 19, 2017Filing document ↗LDA record ↗

Income$12Kfee reported

Client

Name: FIGHT COLORECTAL CANCER
Description: Promotes screening of individuals for colorectal cancer, funding for research
Location: Missouri · United States of America

Registrant

Firm: MS. MARGARET CARVIN
Description: work on issues for Fight Colorectal Cancer funding, prevention, and research
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Congressional Appropriations for National Institutes of Health and the National Cancer Institute, Centers for Disease Control, and the Department of Defense Health Research Grants. The Affordable Care Act. HR 1017/S 479 The Removing Barriers to Colorectal Screening Act
LobbyistsMARGARET CARVIN
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health Resources & Services Administration (HRSA)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

FIGHT COLORECTAL CANCER — Lobbying — Receipts Report